The central nervous system is derived from the neural plate that undergoes a series of complex morphogenetic movements resulting in formation of the neural tube in a process known as neurulation. During neurulation, morphogenesis of the mesenchyme that underlies the neural plate is believed to drive neural fold elevation. The cranial mesenchyme is comprised of the paraxial mesoderm and neural crest cells. The cells of the cranial mesenchyme form a pourous meshwork composed of stellate shaped cells and intermingling extracellular matrix (ECM) strands that support the neural folds. During neurulation, the cranial mesenchyme undergoes stereotypical rearrangements resulting in its expansion and these movements are believed to provide a driving force for neural fold elevation. However, the pathways and cellular behaviors that drive cranial mesenchyme morphogenesis remain poorly studied. Interactions between the ECM and the cells of the cranial mesenchyme underly these cell behaviors. Here we describe a simple ex vivo explant assay devised to characterize the behaviors of these cells. This assay is amendable to pharmacological manipulations to dissect the signaling pathways involved and live imaging analyses to further characterize the behavior of these cells. We present a representative experiment demonstrating the utility of this assay in characterizing the migratory properties of the cranial mesenchyme on a variety of ECM components.
Introduction
Neural tube closure in the cranial region occurs between embryonic day 8.5 (E8.5) and 9.5 in the mouse embryo. Failure to properly close the neural tube in the head results in anencephaly, a common structural birth defect in humans and is incompatible with life. The forces that drive cephalic neural tube closure are generated from both the neural tissue itself and the surrounding epidermis and mesenchyme 3 . In particular expansion of the cranial mesenchyme is thought to be essential for elevation of the cranial neural folds 1, 2 . The cranial mesenchyme is rich in ECM proteins in particular glycosylated proteins such as heparin sulphate proteoglycans, chondroitin sulfates and hyaluronate [4] [5] [6] [7] [8] .
Unlike in the chicken embryo where neural crest cells emigrate from the dorsal neural tube following neural tube closure, the neural crest in the mouse embryo migrates at the same time that the neural folds begin to rise (after the 5 somite stage). Thus during neurulation in the mouse embryo, the cranial mesenchyme is composed of cells derived from the neural crest and the paraxial mesoderm. Neural crest and paraxial mesoderm populations are induced at different times in development; localized in different positions in the embryo and develop into different structures 9, 10 . The paraxial mesoderm originates from the primitive streak and migrates to the anterior region of the embryo to underlie the presumptive neural plate. The neural crest is induced at the junction of the neural plate and epidermal ectoderm, undergoes an epithelial to mesenchyme transition and delaminates just prior to neural fold elevation in the rodent embryo. Neural crest cells migrate along stereotypic paths in the subectodermal paraxial mesoderm to the branchial arch, frontonasal and periocular mesenchyme. The paraxial mesoderm will contribute to some of the bones of the skull vault and muscles of the face; whereas the neural crest will contribute to other bones of the skull and face in addition to cranial nerves [9] [10] [11] . The paraxial mesoderm and neural crest lineages can be differentially marked by the Mesp1-cre and Wnt1-cre transgenic mouse lines, respectively 9 .
The essential role of the cranial mesenchyme in neural tube closure has been inferred from experiments where treatment of rodent embryos with ECM disrupting agents such as hyaluronidase, chondroitinase ABC, heparitinase or Diazo-oxo-norleucine (DON) during neurulation impaired neural tube closure 7, [12] [13] [14] . In these experiments, histological analysis of static sections following neurulation revealed associated dysmorphogeneis of the cranial mesenchyme 7, [12] [13] [14] . However, since the teratogenic agent had access to multiple tissues, it remains to be determined if the cranial mesenchyme is really the target tissue. In support of the conclusion that this tissue is essential for neurulation, the cranial mesenchyme appears abnormal upon histological analyses in some mouse mutants with exencephaly [15] [16] [17] . Still, in most cases, the effect of the mutation on the cellular behavior of the cranial mesenchyme has not been addressed.
We have devised an ex vivo explant assay to directly examine the consequence of genetic mutation or pharmacological manipulation on the behavior of cranial mesenchyme cells more anterior populations of cranial mesenchyme that underlie the anterior neural plate. Our method is also a modification of explant assays performed in the chicken embryo to analyze the migratory behavior of the neural crest with key differences. Previous preparations have explanted the neural crest or the more posterior paraxial mesoderm 19, 20 . Furthermore, during neural fold elevation in the chicken embryo, the neural crest has not yet emigrated from the dorsal neural tube and thus explants taken of the anterior paraxial mesoderm would not contain neural crest cells. In our assay, cranial mesenchyme explants consisting of paraxial mesoderm, neural crest and surface ectoderm are prepared and plated on a substrate. Experimental manipulation including isolation of explants from genetic mutants, plating explants on different ECM or pharmacological treatments can be performed. Cells migrate from the explant and the distance, number and behavior can be analyzed and compared between treatment groups. In addition, this preparation is amendable to analyses of cellular migration by live imaging techniques. After the migration experiment, explants can be fixed and subjected to immunohistochemical analyses to further elucidate the effect of treatments. On the whole, the protocol presented here is a simple ex vivo assay to investigate the behavior of the cranial mesenchyme. As a representative experiment, we utilize this assay to examine the migration of cranial mesenchyme on different extracellular substrates.
Protocol
7. Gently wash the explant by pipeting up and down with a 20 μl pipette tip and pipetman. This will remove loosely attached cells and prevent jagged edges on the explants. 8. Carefully pick up each explant in approximately 10 μl of liquid using a 20 μl pipette tip and pipetman and place at the center of the coated culture well. 9. Add 20 μl of culture media supplemented with 15% FBS to cover the explant. 10. Place plate in a humidified tissue culture incubator (5% CO 2 , 37 °C) for 1-2 hr to allow the explant to attach to the bottom of the dish. View periodically to ensure that the explant does not dry out. 11. When the explant has attached, carefully add to each well 250 μl DMEM supplemented with 10% FBS that has been warmed to 37 °C in a waterbath. Once explants have attached they will not move when plate is gently shaken under microscope. 12. Return dish to tissue culture incubator. 13. After 24 hr, the explants will be firmly attached and cells will begin to emigrate. At this time pharmacological agents can be added to the media. 14. 48 hr after plating, cells will have migrated from the explants. The distance migrated can be visualized and imaged. We typically stop the culture at this point since explants begin to show signs of decreased viability with longer incubations. A vital stain such as acridine orange or trypan blue can also be used to check viability of the explant. 15. At this point images can be acquired to document the distance and number of cells that migrate from the explant. Alternatively, if explants were plated on coverslips, they can be fixed and immunohistochemical analyses performed to visualize proteins of interest.
Critical steps in the protocol
1. Cut explants of approximately the same size. 2. Clear all dissection debris off the dissecting plate as you are dissecting to avoid confusing debris with the desired explanted tissue. 3. When plating explants in wells or on coverslips be sure to place droplet of media with explant in center of well. 4. Allow explant sufficient time to attach before flooding the well with media. 5. Treatment conditions should be standardized for every test substrate and pharmacological agent used. 6. Two explants can be made from each embryo (one from the left and one from the right of the neural tube). 7. When testing migration of cells from mutant mouse lines under different experimental conditions, put one mutant explant in the control group and the other in the treated group.
Troubleshooting
1. If explants fail to attach, increase the allotted time for attachment. In our experience, approximately half of the explants do not attach and larger explants adhere more efficiently. 2. If explants attach to the periphery of the well they will be hard to image. Be sure to place explants in center of the well. 3. Ideally explants will be approximately the same size. However, discrepancies in explant size can be corrected for using the diameter of the explants as a correction factor when quanitating migrations of cells from explants. 4. If contamination occurs be sure sterile working conditions are being used. All tools and work surfaces should be sterilized with 70% ethanol.
Pipets and Petri dishes should be new and sterile. 5. If explants are getting lost during the dissection, periodically remove debris to prevent losing explant. 6. Mastering the dissection is time consuming and takes practice. Optimal magnification, sharp dissection tools and needles help.
Representative Results
The appearance of cells migrating from cranial mesenchyme explants is shown in Figure 2 . We tested migration on various ECM substrates that are present in the cranial mesenchyme during neurulation including Fibronectin (100 mg/ml; Sigma #F1141), Laminin (100 mg/ml; Sigma #L2020), MaxGel ECM (1:500 dilution in DMEM; Sigma #E0282) and Hyaluronic acid (1 mg/ml; Sigma, # 53747). Cells fail to migrate from the explant when no ECM is present (Data not shown) and all substrates tested supported migration of the cells. Both the shape as well as the sizes of cells that migrate from the explants depends upon the substrate. This is expected as previous studies demonstrate that the mechanical forces generated by interaction of cells with different ECM affect both the shape and migratory properties of cells 21 . Figure 1 . Preparation of explants. (A) To prepare explants, E8.5 embryos are dissected from deciduas and extraembryonic tissues. (B) Embryo heads are dissected from the body anterior to the rhombomeres. Explants are prepared by removing tissue from the midline and the outer edges of the head to remove the prechordal plate at the midline and the premigratory neural crest and surface ectoderm at the border, respectively. (C) Explants are prepared by cutting away tissue from the midline and outer edges of the head to remove the prechordal plate at the midline and the premigratory neural crest and surface ectoderm at the borders. (D) Explants are placed in a small volume of media on ECM coated dishes/coverslips and allowed to attach before the addition of more media.
